Inovio Pharmaceuticals (INO) Competitors $2.30 -0.01 (-0.43%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$2.40 +0.10 (+4.52%) As of 09/19/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INO vs. MRNA, KIDS, TMCI, SMLR, CBLL, BFLY, CARL, RXST, DCTH, and NPCEShould you be buying Inovio Pharmaceuticals stock or one of its competitors? The main competitors of Inovio Pharmaceuticals include Moderna (MRNA), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), CeriBell (CBLL), Butterfly Network (BFLY), Carlsmed (CARL), RxSight (RXST), Delcath Systems (DCTH), and NeuroPace (NPCE). Inovio Pharmaceuticals vs. Its Competitors Moderna OrthoPediatrics Treace Medical Concepts Semler Scientific CeriBell Butterfly Network Carlsmed RxSight Delcath Systems NeuroPace Moderna (NASDAQ:MRNA) and Inovio Pharmaceuticals (NASDAQ:INO) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and media sentiment. Is MRNA or INO more profitable? Inovio Pharmaceuticals has a net margin of 0.00% compared to Moderna's net margin of -94.31%. Moderna's return on equity of -25.96% beat Inovio Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Moderna-94.31% -25.96% -20.09% Inovio Pharmaceuticals N/A -163.32%-96.41% Which has preferable valuation & earnings, MRNA or INO? Inovio Pharmaceuticals has lower revenue, but higher earnings than Moderna. Moderna is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioModerna$3.24B3.03-$3.56B-$7.53-3.35Inovio Pharmaceuticals$220K555.55-$107.25M-$2.61-0.88 Do institutionals and insiders hold more shares of MRNA or INO? 75.3% of Moderna shares are owned by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. 11.0% of Moderna shares are owned by insiders. Comparatively, 2.3% of Inovio Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Do analysts prefer MRNA or INO? Moderna currently has a consensus target price of $41.81, suggesting a potential upside of 65.66%. Inovio Pharmaceuticals has a consensus target price of $8.80, suggesting a potential upside of 282.61%. Given Inovio Pharmaceuticals' stronger consensus rating and higher possible upside, analysts plainly believe Inovio Pharmaceuticals is more favorable than Moderna.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Moderna 4 Sell rating(s) 14 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.05Inovio Pharmaceuticals 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to MRNA or INO? In the previous week, Moderna had 19 more articles in the media than Inovio Pharmaceuticals. MarketBeat recorded 20 mentions for Moderna and 1 mentions for Inovio Pharmaceuticals. Moderna's average media sentiment score of 0.75 beat Inovio Pharmaceuticals' score of 0.00 indicating that Moderna is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Moderna 10 Very Positive mention(s) 5 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Inovio Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, MRNA or INO? Moderna has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Inovio Pharmaceuticals has a beta of 1.62, suggesting that its share price is 62% more volatile than the S&P 500. SummaryModerna beats Inovio Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Get Inovio Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INO vs. The Competition Export to ExcelMetricInovio PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$122.23M$3.15B$5.80B$10.40BDividend YieldN/A2.37%5.63%4.60%P/E Ratio-0.8821.0580.5826.78Price / Sales555.55444.33531.83233.20Price / CashN/A46.6037.9961.55Price / Book1.219.6615.776.40Net Income-$107.25M-$53.22M$3.30B$271.80M7 Day Performance-3.36%3.11%5.36%3.49%1 Month Performance24.32%7.56%8.10%9.90%1 Year Performance-64.51%11.15%81.36%28.62% Inovio Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INOInovio Pharmaceuticals3.4367 of 5 stars$2.30-0.4%$8.80+282.6%-65.6%$122.23M$220K-0.88320MRNAModerna4.4728 of 5 stars$23.51-7.4%$41.81+77.8%-62.9%$9.15B$3.24B-3.125,800High Trading VolumeKIDSOrthoPediatrics4.3739 of 5 stars$19.65-3.3%$34.14+73.8%-34.3%$492.63M$204.73M-10.98200TMCITreace Medical Concepts2.6503 of 5 stars$7.22-3.0%$9.83+36.2%+23.0%$456.09M$209.36M-9.14250News CoveragePositive NewsSMLRSemler Scientific2.8611 of 5 stars$29.19+2.3%$81.75+180.1%+19.2%$432.30M$56.29M12.01120Trending NewsAnalyst ForecastGap DownCBLLCeriBell2.5205 of 5 stars$11.57+0.1%$32.14+177.8%N/A$424.16M$65.44M-3.87N/APositive NewsBFLYButterfly Network3.3424 of 5 stars$1.57+1.0%$3.00+91.7%-3.4%$393.97M$82.06M-5.59460News CoverageOptions VolumeGap UpCARLCarlsmedN/A$14.79+7.6%N/AN/A$393.13M$38.27M0.00100RXSTRxSight1.5703 of 5 stars$9.31-1.2%$10.00+7.4%-82.4%$380.97M$139.93M-11.64220Trending NewsDCTHDelcath Systems2.2856 of 5 stars$10.84-2.6%$24.50+126.0%+27.1%$379.18M$37.21M216.8060Positive NewsNPCENeuroPace3.1547 of 5 stars$9.86-1.5%$16.60+68.4%+34.5%$326.17M$79.91M-11.74170Positive News Related Companies and Tools Related Companies Moderna Alternatives OrthoPediatrics Alternatives Treace Medical Concepts Alternatives Semler Scientific Alternatives CeriBell Alternatives Butterfly Network Alternatives Carlsmed Alternatives RxSight Alternatives Delcath Systems Alternatives NeuroPace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INO) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INO Stock Alerts